HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock
HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
Share
Why It Matters
HCA did better than Wall Street expected and raised its outlook. More uninsured patients cost them $400 million, which worried investors.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.
